-
11.PROCESS FOR MAKING MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 审中-公开
Title translation: CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR制造调制器的工艺公开(公告)号:WO2010108162A1
公开(公告)日:2010-09-23
申请号:PCT/US2010/028069
申请日:2010-03-19
Applicant: VERTEX PHARMACEUTICALS INCORPORATED , DEMATTEI, John , LOOKER, Adam, R. , NEUBERT-LANGILLE, Bobbianna , TRUDEAU, Martin , ROEPER, Stefanie , RYAN, Michael, P. , YAP, Dahrika, Milfred Lao , KRUEGER, Brian, R. , GROOTENHUIS, Peter, D.J. , VAN GOOR, Frederick, F. , BOTFIELD, Martyn, C. , ZLOKARNIK, Gregor
Inventor: DEMATTEI, John , LOOKER, Adam, R. , NEUBERT-LANGILLE, Bobbianna , TRUDEAU, Martin , ROEPER, Stefanie , RYAN, Michael, P. , YAP, Dahrika, Milfred Lao , KRUEGER, Brian, R. , GROOTENHUIS, Peter, D.J. , VAN GOOR, Frederick, F. , BOTFIELD, Martyn, C. , ZLOKARNIK, Gregor
IPC: C07D215/233
CPC classification number: C07C205/43 , C07C68/02 , C07C69/96 , C07C201/08 , C07C213/02 , C07C229/66 , C07D215/233 , C07D215/56 , G01N33/5041 , G01N33/6872 , Y02P20/55
Abstract: The invention provides a process for the preparation of a compound of Formula 1; comprising coupling a carboxylic acid of Formula 2; with an aniline of Formula 3; in the presence of a coupling agent.
Abstract translation: 本发明提供了制备式1化合物的方法; 包括偶联式2的羧酸; 与式3的苯胺; 在偶联剂存在下。
-
12.SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE 审中-公开
Title translation: N- [2,4-BIS(1,1-二甲基乙基)-5-羟基苯基] -1,4-二氢-4-氧代喹啉-3-羧酰胺的固体形式公开(公告)号:WO2009038683A3
公开(公告)日:2010-08-26
申请号:PCT/US2008010728
申请日:2008-09-15
Applicant: VERTEX PHARMA , DEMATTEI JOHN , FENG YUSHI , HARRISON CRISTIAN , LOOKER ADAM , MUDUNURI PRAVEEN , ROEPER STEFANIE , ZHANG YUEGANG
Inventor: DEMATTEI JOHN , FENG YUSHI , HARRISON CRISTIAN , LOOKER ADAM , MUDUNURI PRAVEEN , ROEPER STEFANIE , ZHANG YUEGANG
IPC: C07D215/233
CPC classification number: C07D215/56 , A61K31/47 , A61K45/06 , C07D215/233
Abstract: Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide are described herein, including crystalline forms thereof.
Abstract translation: 本文描述了固体形式的N- [2,4-双(1,1-二甲基乙基)-5-羟基苯基] -1,4-二氢-4-氧代喹啉-3-甲酰胺,包括其结晶形式。
-